JULIO OLMEDA: Open Payments
NPI 1326356692 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 14 payments from 9 companies in 2025. Trend: 2023 $132 · 2024 $459 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $312 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| PFIZER INC. | 2 | $48 |
| Abbott Laboratories | 1 | $44 |
| ABBVIE INC. | 2 | $39 |
| Eisai Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $27 |
| Otter Pharmaceuticals, LLC | 1 | $22 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
Products named: PERCEPT PC BRAINSENSE, KESIMPTA, INFINITY, Leqembi, AMYVID, NURTEC ODT, PAXLOVID, SYMPAZAN.
Industry payments across TX — which companies pay providers there.
